Family Health International (FHI) announced that the US Agency for International Development (USAID) has awarded the organization the Preventive Technologies Agreement (PTA), providing up to $175 million in funding over five years to continue FHI’s evaluation of innovative HIV-AIDS prevention technologies and strategies.
The award, which continues nearly 40 years of USAID support for prevention research leveraging FHI’s scientific expertise, involves the completion of two clinical trials of antiretroviral drugs for prevention, and the development of new trials and other research and scientific support activities that advance USAID’s global agenda for HIV prevention, including the integration of family planning and HIV services.
For the full press release, see:
http://www.fhi.org/en/AboutFHI/Media/Releases/res_Prevention_Technologie... [2]
